Abstract:The fungal genusMonascus is used to prepare red fermented rice as a natural food colorant and traditional medicine in China for thousands of years. Monascus fermentation products contain numerous active constituents, and the components isolated from the fungus exert several biological actions and produce hypocholesterolemic, antihypertensive, antitoxic and antitumoral effects. Results of several studies in animals and humans suggest that Monascus fermentation products can effectively regulate serum cholesterol and glyceride levels, and they are therefore used as dietary supplements for medical therapy. In 1979, Prof. Endo isolated monacolin K from cultures of Monascus purpureus and showed that this was capable of inhibiting 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase), an enzyme for the synthesis of cholesterol. Today, the monacolin analogs are still considered the treatment of choice for hyperlipoproteinemia and one of the most important categories of available drugs. More than 20 monacolin analog structures were isolated and elucidated from Monascus metabolites, including the structure ofmonacophenyl oncementioned in a patent as a hypothetical compound with antihypercholesterolemic activity and later isolated from theM. purpureus. In our continuing search for HMG-CoA reductase inhibitors from the EtOAc portion of the EtOH extract of M. purpureus, two unusual and rare isomeric aromatic monacolin analogs were isolated and elucidated, named as monacophenylone A (1) and B (2) (Fig. 1). The extensive application of 1D and 2D NMR techniques and high-resolution ESI-MS spectrometry were performed to characterize its structure and establish the complete H and C resonance assignments. ** Correspondence to: Xiaoya Shang, Beijing Key Laboratory of Bioactive Substances and Functional Foods, Beijing Union University, Beijing 100191, China. E-mail: shangxiaoya@ buu.edu.cn

Constituents Isolated from the Fungus Monascus sp.

Structure Elucidation and NMR Assignments of Two Unusual Isomeric Aromatic Monacolin Analogs from Monascus Purpureus

Three New Isoflavonoid Glycosides From The Mangrove-Derived Actinomycete Micromonospora Aurantiaca 110b

Chemical Constituents from Monascus anka

Structural elucidation and complete NMR spectral assignments of Monascus monacolin analogues

Isolation and Structure Elucidation of New Metabolites from the Mariana-Trench-Associated Fungus Aspergillus Sp. SY2601.

Structural Elucidation and Complete NMR Spectral Assignments of Monascus Monacolin Analogs

A NEW EUDESMANE SESQUITERPENOID FROM THE MARINE-DERIVED FUNGUS Penicillium Sp. HK1-22

Chemical Constituents of Monascus Anka

Anthraquinone derivatives from Micromonospora rhodorangea.

New Chemical Constituents from the Endophyte Streptomyces Species LR4612 Cultivated on Maytenus Hookeri

Secondary Metabolites from Fungus Alternaria Sp. CIB 108

HMG-CoA Reductase Inhibitors from Monascus-Fermented Rice

Investigations into Chemical Components from Monascus purpureus with Photoprotective and Anti-Melanogenic Activities

New Constituents from Eleutherine americana

Chemical Constituents from the Fruiting Bodies of the Basidiomycete Albatrellus Sp.

The Chemical Constituents Of The Fungus Stereum Sp.

Chemical Constituents from Fermented Broth and Mycelium of the Basidiomycete Lacrymaria Velutina

A new compound from Stereum insigne CGMCC5.57

Tumonoic Acids K and L, Novel Metabolites from the Marine-Derived Fungus Penicillium Citrinum

Chemical Constituents from the Cultures of Fungus Xylaria Polymorpha